Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole

Abstract

Genes have been identified which either change markedly or consistently in breast cancer after 14 days treatment with letrozole. These are new important data in understanding letrozole's molecular mechanism of action in breast cancers.